BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24634097)

  • 1. Impact of infectious complications on gastric cancer recurrence.
    Hayashi T; Yoshikawa T; Aoyama T; Hasegawa S; Yamada T; Tsuchida K; Fujikawa H; Sato T; Ogata T; Cho H; Oshima T; Rino Y; Masuda M
    Gastric Cancer; 2015 Apr; 18(2):368-74. PubMed ID: 24634097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer.
    Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
    Ann Surg Oncol; 2013 May; 20(5):1575-83. PubMed ID: 23076557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of infectious complications after curative gastric cancer surgery.
    Han WH; Oh YJ; Eom BW; Yoon HM; Kim YW; Ryu KW
    Eur J Surg Oncol; 2020 Jul; 46(7):1233-1238. PubMed ID: 32362466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative.
    Dann GC; Squires MH; Postlewait LM; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Levine EA; Jin LX; Cho CS; Winslow ER; Russell MC; Cardona K; Staley CA; Maithel SK
    J Surg Oncol; 2015 Aug; 112(2):195-202. PubMed ID: 26240027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of postoperative C-reactive protein elevation versus complication occurrence: a multicenter validation study.
    Kurokawa Y; Yamashita K; Kawabata R; Fujita J; Imamura H; Takeno A; Takahashi T; Yamasaki M; Eguchi H; Doki Y
    Gastric Cancer; 2020 Sep; 23(5):937-943. PubMed ID: 32314097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Infectious Complications on Survival and Recurrence of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study.
    Tamagawa H; Aoyama T; Numata M; Kazama K; Atsumi Y; Iguchi K; Ju M; Sawazaki S; Sato S; Kano K; Ohshima T; Yamada T; Godai T; Higuchi A; Saeki H; Yukawa N; Rino Y
    Anticancer Res; 2022 May; 42(5):2763-2769. PubMed ID: 35489757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of Peritoneal Drain Placement After Total Gastrectomy for Gastric Adenocarcinoma: A Multi-institutional Analysis from the US Gastric Cancer Collaborative.
    Dann GC; Squires MH; Postlewait LM; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords DS; Jin LX; Cho CS; Winslow ER; Russell MC; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S888-97. PubMed ID: 26023037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the clinically most relevant postoperative complications after gastrectomy: a population-based cohort study.
    Gertsen EC; Goense L; Brenkman HJF; van Hillegersberg R; Ruurda JP;
    Gastric Cancer; 2020 Mar; 23(2):339-348. PubMed ID: 31482476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma.
    Nakanishi Y; Ohara M; Domen H; Shichinohe T; Hirano S; Ishizaka M
    World J Surg Oncol; 2013 May; 11():98. PubMed ID: 23683476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for recurrence in T1-2N0 gastric cancer in the United States and China.
    Cao L; Selby LV; Hu X; Zhang Y; Janjigian YY; Tang L; Coit DG; Brennan MF; Strong VE
    J Surg Oncol; 2016 Jun; 113(7):745-9. PubMed ID: 27040753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Pawlik TM; Weber SM; Poultsides G; Schmidt C; Votanopoulos K; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Jin LX; Levine E; Cho CS; Bloomston M; Winslow E; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2014 Dec; 21(13):4202-10. PubMed ID: 25047464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
    Ishigami S; Uenosono Y; Arigami T; Yanagita S; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Nakajo A; Maemura K; Natsugoe S
    World J Surg Oncol; 2014 Nov; 12():350. PubMed ID: 25407392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer perforation: experience from a tertiary care hospital.
    Kandel BP; Singh Y; Singh KP; Khakurel M
    JNMA J Nepal Med Assoc; 2013; 52(191):489-93. PubMed ID: 24907957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
    Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of complications following open, laparoscopic and robotic gastrectomy].
    Lan X; Xi H; Zhang K; Cui J; Li M; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):184-189. PubMed ID: 28226353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.
    Kanda M; Mizuno A; Fujii T; Shimoyama Y; Yamada S; Tanaka C; Kobayashi D; Koike M; Iwata N; Niwa Y; Hayashi M; Takami H; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2016 Jun; 23(6):1934-40. PubMed ID: 26847679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer.
    Fukuchi M; Ishiguro T; Ogata K; Kimura A; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
    Anticancer Res; 2015 Nov; 35(11):6183-7. PubMed ID: 26504048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
    Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
    Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer.
    Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S
    Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.